BiVictriX Therapeutics PLC (GB:BVX)
LSE:BVX
Holding GB:BVX?
Track your performance easily

BiVictriX Therapeutics PLC (BVX) Share Price & Analysis

0 Followers

BVX Stock Chart & Stats


Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

3.47%0.00%0.00%96.53%
3.47%
Insiders
0.00% Other Institutional Investors
96.53% Public Companies and
Individual Investors

BVX FAQ

What was BiVictriX Therapeutics PLC’s price range in the past 12 months?
BiVictriX Therapeutics PLC lowest share price was 7.00p and its highest was 14.25p in the past 12 months.
    What is BiVictriX Therapeutics PLC’s market cap?
    Currently, no data Available
    When is BiVictriX Therapeutics PLC’s upcoming earnings report date?
    BiVictriX Therapeutics PLC’s upcoming earnings report date is Mar 10, 2025 which is in 127 days.
      How were BiVictriX Therapeutics PLC’s earnings last quarter?
      BiVictriX Therapeutics PLC released its earnings results on Aug 01, 2024. The company reported -0.018p earnings per share for the quarter, missing the consensus estimate of N/A by -0.018p.
        Is BiVictriX Therapeutics PLC overvalued?
        According to Wall Street analysts BiVictriX Therapeutics PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does BiVictriX Therapeutics PLC pay dividends?
          BiVictriX Therapeutics PLC does not currently pay dividends.
          What is BiVictriX Therapeutics PLC’s EPS estimate?
          BiVictriX Therapeutics PLC’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does BiVictriX Therapeutics PLC have?
          BiVictriX Therapeutics PLC has 82,526,085 shares outstanding.
            What happened to BiVictriX Therapeutics PLC’s price movement after its last earnings report?
            BiVictriX Therapeutics PLC reported an EPS of -0.018p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of BiVictriX Therapeutics PLC?
              Currently, no hedge funds are holding shares in GB:BVX
              ---

              BiVictriX Therapeutics PLC Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -28.57%
              12-Months-Change

              Fundamentals

              Return on Equity
              -103.99%
              Trailing 12-Months
              Asset Growth
              -13.77%
              Trailing 12-Months

              Company Description

              BiVictriX Therapeutics PLC

              BiVictriX Therapeutics PLC is a drug development company. It has developed its proprietary Bi-Cygni technology which utilises Antibody Drug Conjugates for the treatment of various cancers including Acute Myeloid Leukaemia.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              ValiRx plc
              Scancell Holdings
              Sareum Holdings
              Genedrive
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis